Effects of methylphenidate on discounting of delayed rewards in attention deficit/hyperactivity disorder. - Wikidata - wikimedia - TriplyDB

Effects of methylphenidate on discounting of delayed rewards in attention deficit/hyperactivity disorder.

Effects of methylphenidate on discounting of delayed rewards in attention deficit/hyperactivity disorder.

http://www.wikidata.org/entity/Q34012703

about

Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD)Impulsive delayed reward discounting as a genetically-influenced target for drug abuse prevention: a critical evaluation Decision making: effects of methylphenidate on temporal discounting in nonhuman primates.Effects of smoking abstinence on impulsive behavior among smokers high and low in ADHD-like symptoms.Reinforcement, dopamine and rodent models in drug development for ADHD Reinforcement and Stimulant Medication Ameliorate Deficient Response Inhibition in Children with Attention-Deficit/Hyperactivity Disorder.The roles of dopamine and serotonin in decision making: evidence from pharmacological experiments in humans New developments in human neurocognition: clinical, genetic, and brain imaging correlates of impulsivity and compulsivity DAT1 and COMT effects on delay discounting and trait impulsivity in male adolescents with attention deficit/hyperactivity disorder and healthy controls.Reinforcement enhances vigilance among children with ADHD: comparisons to typically developing children and to the effects of methylphenidate.A functional variant of the serotonin transporter gene (SLC6A4) moderates impulsive choice in attention-deficit/hyperactivity disorder boys and siblings.Animal models to guide clinical drug development in ADHD: lost in translation?The utility of rat models of impulsivity in developing pharmacotherapies for impulse control disorders.The effect of methylphenidate and rearing environment on behavioral inhibition in adult male rats.Effect of brain structure and function on reward anticipation in children and adults with attention deficit hyperactivity disorder combined subtype.Choice impulsivity: Definitions, measurement issues, and clinical implications.Low Dopamine D2/D3 Receptor Availability is Associated with Steep Discounting of Delayed Rewards in Methamphetamine Dependence.Connectivity strength of dissociable striatal tracts predict individual differences in temporal discounting Individual differences in delay discounting under acute stress: the role of trait perceived stress Hot and Cool Executive Functions in Children with Attention-Deficit/Hyperactivity Disorder and Comorbid Oppositional Defiant Disorder Improving working memory in children with attention-deficit/hyperactivity disorder: the separate and combined effects of incentives and stimulant medication.Functional Genetic Variation in Dopamine Signaling Moderates Prefrontal Cortical Activity During Risky Decision Making.An efficient operant choice procedure for assessing delay discounting in humans: initial validation in cocaine-dependent and control individuals.Increased Delay Discounting on a Novel Real-Time Task among Girls, but not Boys, with ADHD Decision making: from neuroscience to psychiatry The effects of performance-based rewards on neurophysiological correlates of stimulus, error, and feedback processing in children with ADHD.Changing delay discounting in the light of the competing neurobehavioral decision systems theory: a review.Test-retest reliability and construct validity of the Experiential Discounting Task.ADHD, altered dopamine neurotransmission, and disrupted reinforcement processes: implications for smoking and nicotine dependence.Developmental context and treatment principles for ADHD among college students.An evaluation of the pharmacokinetics of methylphenidate for the treatment of attention-deficit/ hyperactivity disorder.Possible role of a dysregulation of the endogenous opioid system in antisocial personality disorder.Pharmacotherapies for decreasing maladaptive choice in drug addiction: Targeting the behavior and the drug.Altered experiential, but not hypothetical, delay discounting in schizophrenia.Temporal discounting of monetary rewards in children and adolescents with ADHD and autism spectrum disorders.Methylphenidate and emotional-motivational processing in attention-deficit/hyperactivity disorder.Adolescent Exposure to Methylphenidate Increases Impulsive Choice Later in Life.Investigating the Impact of Cognitive Load and Motivation on Response Control in Relation to Delay Discounting in Children with ADHD.Acute effects of methylphenidate on impulsivity and attentional behavior among adolescents comorbid for ADHD and conduct disorder.Effects of methylphenidate on executive functioning in attention-deficit/hyperactivity disorder across the lifespan: a meta-regression analysis.

P2860

Q22061981-9E493380-60ED-4A75-A1E5-E7831A53AC6E Q26782950-7F252C3B-A646-4FE3-BB23-06D3D432900B Q30380367-69E08BC2-0AFE-4CE6-BD19-91305A25D16D Q30459647-2BD2A008-A131-4633-A094-5E68333E74BC Q30524906-11D3CE44-1719-4DE8-BF7A-49892B4E9936 Q30680214-8A0EA6DA-7452-4CCF-98B0-15BECEBFA1E2 Q33706269-759EA108-89DF-4526-BA29-987058EC8F7B Q33961196-8CB3BEB8-6EF0-4A67-93CC-A624C43AC69E Q34204584-9B6B318A-7365-4804-9FC7-1A88D8DDF7CA Q34725704-633A1869-7AEE-44FF-A6BB-13F1D0679320 Q35100184-9D6C0B96-EC85-4133-8F84-34407D562DA8 Q35589937-2A6D7FD1-B8E4-46C0-82AE-06FF0A83E0E3 Q35589965-2EAD1ABE-9A6A-48D8-A452-B4CA25D9D4D8 Q35687707-35D83E30-23CD-4D33-93AF-ED8A26AA22DE Q35790441-EE4E73E5-7FFD-49A1-92C7-FFA9B2307D48 Q35951113-1357B835-F9F1-446C-A177-D9C7008C79DF Q35965848-C8928AD3-0095-41ED-A1D4-EB1BD1FC9E2B Q36080249-7415E77E-EE6C-404C-AC40-C8203BA95262 Q36104610-B9C503BB-2B39-4AA8-BAB3-5F8604D1FDFC Q36108446-F1E7E20E-E097-48A6-91E0-3810F3226C20 Q36174459-B109FC11-F33D-4232-9949-52CC79C32DC5 Q36449651-4065FF0F-C131-4217-B95B-76C82FCB98EB Q36503693-C9C29C12-EC58-4D96-9C49-697A8266920F Q36657918-A11B52C8-6447-4187-9135-6CA6407272D2 Q36897293-3753C871-D7BC-47DD-BF14-8C7C43044495 Q37253902-01840E01-53E8-49E2-8C71-44C34E4F83AF Q37567155-CB2D897C-A364-440A-B560-F4C67BE403F0 Q37648270-CA142FAE-7CA1-4E82-83DA-DEDFC27D0064 Q37732338-BB1CF4EF-7123-4A7E-BCBD-21BB327C224C Q38051039-CF98D847-5C09-4B35-B1EF-6CB180AD7E7A Q38214174-9C508D54-A936-4B91-88A1-EA2BED6E280B Q38562081-641370F5-0533-4359-9DAC-1AC43A3F82B7 Q38664308-26C0678B-DA18-45E7-9BAB-C262747AF863 Q38761062-2BAC202B-83CA-40D1-93A0-AC3E2C7FF051 Q39529383-ADF1356C-A055-47A5-B2B5-AA45A9B05DB7 Q40017625-EC717D84-26C4-4DEE-9D6B-8012F8ED9ED0 Q46349469-193AE9C5-5F78-4E94-9702-BFB0EC4BFE6D Q47378021-0B06F346-0F06-4324-9A1A-1E65B76E15F7 Q50479023-93FACCB5-17E8-4EB7-87FE-1B0D442DA243 Q50659644-9723EABB-367F-415B-A8F3-EB023D23906B

P2860

Effects of methylphenidate on discounting of delayed rewards in attention deficit/hyperactivity disorder.

http://www.wikidata.org/entity/Q34012703

description

2009 nî lūn-bûn

@nan

2009 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Effects of methylphenidate on ...... eficit/hyperactivity disorder.

@ast

Effects of methylphenidate on ...... eficit/hyperactivity disorder.

@en

Effects of methylphenidate on ...... eficit/hyperactivity disorder.

@nl

type

label

Effects of methylphenidate on ...... eficit/hyperactivity disorder.

@ast

Effects of methylphenidate on ...... eficit/hyperactivity disorder.

@en

Effects of methylphenidate on ...... eficit/hyperactivity disorder.

@nl

prefLabel

Effects of methylphenidate on ...... eficit/hyperactivity disorder.

@ast

Effects of methylphenidate on ...... eficit/hyperactivity disorder.

@en

Effects of methylphenidate on ...... eficit/hyperactivity disorder.

@nl

P1433

Q34012703-2A48D96D-231E-454C-BDA9-CE9BA03CA3C5

P1476

Q34012703-27F8472D-8F32-487E-8D1B-9E381836A94B

P2093

Q34012703-3F8A1624-A565-47DC-8AAA-2B5560959BA5

Q34012703-43F521DF-CE2F-4752-A612-16332225683F

Q34012703-58DC076E-45D0-4B4F-8476-8C60DDDEA058

Q34012703-59FE0C77-B93D-41CF-861A-2FB2540DFF73

Q34012703-76736971-FBE6-4537-ACA7-FF2D2CD166EE

Q34012703-850DB3CE-92CB-4E5A-B697-735E1569C7E9

Q34012703-A9CAB015-D9CE-4067-AF77-6002316BA528

Q34012703-C1505F32-5140-4E98-A6AB-A5CE055BAE0D

P2860

Q34012703-023C6332-4534-4C3C-B5B4-10FCA4298301

Q34012703-028D334E-9351-4B6F-9826-DE5A8D0D8804

Q34012703-0301B83D-8D04-4024-95E6-DB5029B64B56

Q34012703-0B37BBEB-ACC2-41DF-824D-31E2C8A9C154

Q34012703-0FD15F5E-8EA4-4D11-91D4-1CE1C02BFB53

Q34012703-1607FBCF-A2B4-4D37-88F6-5FC76C956256

Q34012703-1D985F6D-C08D-4943-A822-5F2678478111

Q34012703-2F1D6ECD-8029-47BE-A167-9BF953CB189A

Q34012703-324696C2-EC60-4188-BB62-569C9CCCDDDF

Q34012703-36A8F0A1-4D62-4233-9C58-F3422D84AAC2

P304

Q34012703-41388630-09AE-450A-8A0A-F3C627352979

P31

Q34012703-C68F4955-2DE2-45D0-BE59-CB21F2918438

P356

Q34012703-01ECA599-678E-4E22-860D-2087FF09F84C

P433

Q34012703-504E6A83-534B-4AF4-8F77-DE14F72F0153

P478

Q34012703-87D3B7E5-5EBD-4F17-8F1B-4A18C0091D33

P577

Q34012703-DB00CA60-4165-447A-8726-46DD44716C36

P5875

Q34012703-9B0BF923-075C-478E-B326-8F6C5C92C6FC

P698

Q34012703-F5682000-4765-4584-8DE9-5E8EB64B318A

P921

Q34012703-3D1A0BAB-2431-4FC0-BBFB-317D638859F8

Q34012703-EA2057E4-DDB7-4D48-8FFB-7DCC81511D13

P932

Q34012703-D1A62C2B-C827-4502-A0FF-237C406D9FFF

P356

P1433

Experimental and Clinical Psychopharmacology

P1476

Effects of methylphenidate on ...... eficit/hyperactivity disorder.

@en

P2093

Brady Reynolds

http://www.w3.org/2001/XMLSchema#string

Brian P Gangloff

http://www.w3.org/2001/XMLSchema#string

James G Waxmonsky

http://www.w3.org/2001/XMLSchema#string

Jessica D Rhodes

http://www.w3.org/2001/XMLSchema#string

Keri Shiels

http://www.w3.org/2001/XMLSchema#string

Larry W Hawk

http://www.w3.org/2001/XMLSchema#string

Rebecca J Mazzullo

http://www.w3.org/2001/XMLSchema#string

William E Pelham

http://www.w3.org/2001/XMLSchema#string

P2860

Practice Parameter for the Assessment and Treatment of Children and Adolescents With Attention-Deficit/Hyperactivity Disorder

NIMH Diagnostic Interview Schedule for Children Version IV (NIMH DISC-IV): description, differences from previous versions, and reliability of some common diagnoses

Clinical practice guideline: treatment of the school-aged child with attention-deficit/hyperactivity disorder

Development of a new once-a-day formulation of methylphenidate for the treatment of attention-deficit/hyperactivity disorder: proof-of-concept and proof-of-product studies

A dynamic developmental theory of attention-deficit/hyperactivity disorder (ADHD) predominantly hyperactive/impulsive and combined subtypes

Single- and multiple-dose pharmacokinetics of an oral once-a-day osmotic controlled-release OROS (methylphenidate HCl) formulation

Impulsive choice and environmental enrichment: effects of d-amphetamine and methylphenidate

The cognitive-energetic model: an empirical approach to attention-deficit hyperactivity disorder.

Once-a-day Concerta methylphenidate versus three-times-daily methylphenidate in laboratory and natural settings.

The ecological validity of delay aversion and response inhibition as measures of impulsivity in AD/HD: a supplement to the NIMH multimodal treatment study of AD/HD.

P304

291-301

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1037/A0017259

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

17

http://www.w3.org/2001/XMLSchema#string

P577

2009-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26869847

http://www.w3.org/2001/XMLSchema#string

P698

19803628

http://www.w3.org/2001/XMLSchema#string

P921

attention deficit hyperactivity disorder

P932

2908283

http://www.w3.org/2001/XMLSchema#string